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Trichloroethylene (TCE) is a widely used industrial chemical
and a common environmental contaminant. It is a well-known
carcinogen in rodents and a probable carcinogen in humans.
Studies utilizing panels of mouse inbred strains afford a unique
opportunity to understand both metabolic and genetic basis for
differences in responses to TCE. We tested the hypothesis that
strain- and liver-specific toxic effects of TCE are genetically
controlled and that the mechanisms of toxicity and susceptibility
can be uncovered by exploring responses to TCE using a diverse
panel of inbred mouse strains. TCE (2100 mg/kg) or corn oil
vehicle was administered by gavage to 6- to 8-week-old male mice
of 15 mouse strains. Serum and liver were collected at 2, 8, and
24 h postdosing and were analyzed for TCE metabolites,
hepatocellular injury, and gene expression of liver. TCE metab-
olism, as evident from the levels of individual oxidative and
conjugative metabolites, varied considerably between strains. TCE
treatment-specific effect on the liver transcriptome was strongly
dependent on genetic background. Peroxisome proliferator–
activated receptor–mediated molecular networks, consisting of
the metabolism genes known to be induced by TCE, represent
some of the most pronounced molecular effects of TCE treatment
in mouse liver that are dependent on genetic background.
Conversely, cell death, liver necrosis, and immune-mediated
response pathways, which are altered by TCE treatment in liver,
are largely genetic background independent. These studies pro-
vide better understanding of the mechanisms of TCE-induced
toxicity anchored on metabolism and genotype-phenotype corre-
lations that may define susceptibility or resistance.
Key Words: trichloroethylene; metabolism; genetics; peroxisome
proliferator-activated receptor alpha; acute exposure; gene
expression.
Trichloroethylene (TCE), a ubiquitous environmental con-
taminant, continues to be a major recurrent challenge in
mechanistic and regulatory toxicology (NRC, 2006). TCE is
widely used as an industrial chlorinated organic solvent, and
the potential for human exposure is substantial from a variety
of sources such as indoor and ambient air, soil, and
groundwater. TCE is thought to cause adverse health effects
through multiple organ toxicities (IARC, 1995). Acute
exposure results primarily in the adverse effects on the nervous
system, whereas long-term exposures can result in liver- (Bull,
2000), kidney- (Lash et al., 2000b), and neurotoxicity (Barton
and Clewell, 2000), as well as autoimmune disorders (Cooper
et al., 2009). Adverse reproductive and developmental effects
of TCE have also been reported (Pastino et al., 2000).
Although TCE is classified as ‘‘reasonably anticipated to be
a human carcinogen’’ (U.S. DHHS/PHS/NTP, 2005), it has
been difficult to achieve consensus on its risks to humans
(NRC, 2006). Despite the fact that a large body of information
exists on adverse health effects of TCE, significant gaps remain
because of the complexity of TCE metabolism and apparent
existence of many modes of action.
The metabolic transformation of TCE involves formation of
many metabolites that vary in their toxicity and organ-specific
effects (Lash et al., 2000a). Cytochrome P450–dependent
oxidation and glutathione conjugation are two primary pathways
for metabolism in both humans and animals, albeit important
species differences exist in the relative contribution of each
pathway to liver and kidney toxicity that ensues (NRC, 2006).
Although the precise mechanisms of TCE action and the reasons
for species-specific differences in toxicity are yet to be fully
understood, it is well accepted that knowledge of TCE
metabolism is critical for determining susceptibility, target organ
specificity, and gender and species differences (NRC, 2006).
Two recent National Research Council reports addressing the
challenges in chlorinated solvent toxicity (NRC, 2006, 2010)
posit that the development of sensitive analytical methodologies
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for assessment of TCE metabolism and quantitative assessment
of the extent of interindividual variability in TCE metabolism are
among the critical needs in TCE assessment.
The development of a sensitive analytical method for
key oxidative and glutathione conjugation TCE metabolites
dichloroacetic acid (DCA), trichloroacetic acid (TCA), S-(1,2-
dichlorovinyl)-L-cysteine (DCVC), and S-(1,2-dichlorovinyl)
glutathione (DCVG) allows for an increase in throughput and
a decrease in the number of animals required for mechanistic
studies on TCE in rodents (Kim et al., 2009b). This method was
used to investigate the time-concentration profiles of DCA,
TCA, DCVG, and DCVG formation and elimination in the
mouse (Kim et al., 2009a). In this study, we aimed to quantify
the extent of interstrain differences, analogous to interindividual
differences in humans (Rusyn et al., 2010), in TCE metabolism
through oxidative and glutathione conjugation pathways in
a panel of genetically diverse mouse strains. We found that TCE
metabolism varies considerably between strains, and this
knowledge may not only be used to determine the extent of
within-species variability but could also serve as the scientific
basis for selection of strains for assessment of organ-specific
toxic effects in longer term studies. In addition, to advance the
understanding of the mode of action of TCE, including
interindividual differences in toxicity, we performed pathway-
based assessment of the liver gene expression data. The mouse
population experimental approach revealed that TCE-induced
liver toxicity is a predominant genetic background–independent
mode of action, whereas peroxisomal proliferation is a key
genotype-dependent pathway altered by TCE.
MATERIALS AND METHODS
Animals and treatments. Male mice (aged 7–9 weeks) were obtained from
the Jackson Laboratory (Bar Harbor, ME) and housed in polycarbonate cages
on Sani-Chips irradiated hardwood bedding (P. J. Murphy Forest Products
Corp., Montville, NJ). Animals were fed NTP-2000 wafer diet (Zeigler
Brothers, Inc., Gardners, PA) and water ad libitum on a 12-h light-dark cycle.
Mice utilized in this study comprise 14 inbred strains that have been densely
genotyped (Frazer et al., 2007): 129S1/SvImJ, A/J, BALB/cByJ, BTBRþ tf/J,
CAST/EiJ, C3H/HeJ, C57BL/6J, DBA/2J, FVB/NJ, MOLF/EiJ, NOD/LtJ,
NZW/LacJ, PWD/PhJ, and KK/HlJ. An F1 hybrid mouse strain, B6C3F1/J, was
also used. On the day of treatment (at 9 A.M.), fed mice were treated orally by
gavage with TCE (2100 mg/kg) in corn oil (vehicle, 10 ml/kg). Mice were
sacrificed at 2, 8, and 24 h after treatment. The experimental design was
selected based on the previous pharmacokinetic analysis of TCE metabolism in
male B6C3F1 mice (Kim et al., 2009b). Liver and kidney sections were placed
in neutral buffered formalin, and the remainder of the tissue was frozen in
liquid nitrogen and stored at 80C. Hematoxylin/eosin-stained sections of
liver and kidney were evaluated using light microscopy. Blood was collected
from vena cava, and serum was prepared by centrifugation using Z-gel tubes
(Sarstedt, Germany) according to the manufacturer’s instructions and stored
at 80C. Serum tissue damage biomarkers (blood urea nitrogen, BUN; alanine
aminotransferase, ALT; and aspartate aminotransferase, AST) were analyzed
using standard protocols. All studies were conducted with approval of the
Institutional Animal Care and Use Committee.
Determination of TCE metabolites in serum. Concentrations of DCA,
TCA, DCVG, and DCVC in mouse serum were determined as detailed
elsewhere (Kim et al., 2009a). DCA and TCA were measured by high
performance liquid chromatography-electrospray ionization tandem mass
spectrometry (HPLC-ESI-MS/MS) with a Finnigan Surveyor autosampler and
pump coupled to a Finnigan TSQ Quantum triple-quadrupole mass spectrom-
eter (Thermo Finnigan, San Jose, CA). Determination of DCVC and DCVG
was performed by HPLC-ESI-MS/MS with an Aquity UPLC (Waters, Milford,
MA) system coupled to a TSQ Quantum Ultra triple-quadrupole mass analyzer
(Thermo Finnigan) using a heat-assisted electrospray ionization source in
positive ion mode. Quantification was based on peak areas relative to the stable
FIG. 1. Interstrain variability in TCE metabolism in the mouse. Serum
levels of TCA, DCA, DCVG, and DCVC were assessed 2, 8, and 24 h
following an acute dose (2100 mg/kg, intragastric in corn oil vehicle) of TCE
administered to mice of 14 inbred and 1 hybrid strains and were measured by
liquid chromatography coupled with tandem mass spectrometry. See
Supplementary table 2 for strain average values, SDs, number of animals in
each group, and the coefficients of variability of the measurements.
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FIG. 2. Whole-liver gene expression data (24 h after TCE treatment) were used for the principal component (panels A–C) and DWD (panels D and E) analyses
(strains are identified by colors; ‘‘o’’ vehicle treatment; ‘‘þ’’ TCE treatment). (E) A distribution of the t statistic values (each was derived from DWD analysis) of
2000 random permutations of the data is shown in comparison to the t statistic (green vertical line) derived from the DWD analysis (panel D). (F) A heatmap of
genes identified as significant (p ¼ 0.0005 under 2000 permutations, FDR ¼ 0.041) TCE-specific response using DWD analysis. The color bar identifies up- and
downregulated genes. See Supplementary table 3 for a complete list of genes and gene expression values.
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isotope-labeled internal standards, and the calibration curve was constructed in
each batch. Limits of detection were determined by a signal-to-noise ratio of
3:1 and were as follows: TCA, 0.4 nmol/ml; DCA, 0.01 nmol/ml; DCVG and
DCVC, 0.001 nmol/ml. ANOVA was used to treat metabolite differences as
a function of strain. To evaluate whether there was a significant strain effect on
the concentrations of TCE metabolites in serum, a one-way ANOVA model
(concentration ¼ strain þ error) was applied for each of TCA, DCA, DCVC,
and DCVG at each time point (2, 8, and 24 h). For each model, the ANOVA F
statistic was used to assess the significance of the strain effect.
Microarray analysis of liver gene expression. Total RNA was isolated
from frozen liver samples (three vehicle and three TCE-treated animals per strain,
24-h time point) using the RNeasy (Qiagen, Valencia, CA) kit according to the
manufacturer’s instructions. RNA concentration and quality were assessed using
ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE) and
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA), respectively.
All RNA samples were hybridized to arrays individually; none were pooled.
RNA amplifications and labeling were performed using Low RNA Input Linear
Amplification kits (Agilent Technologies). Following the recommendations
of the Toxicogenomics Research Consortium’s standardization experiment
(Bammler et al., 2005), a two-color array design was used. Specifically,
750 ng of total RNA from each mouse liver was amplified and labeled with
fluorescent dye Cy5, and 750 ng of a common mouse reference RNA (Icoria Inc.,
RTP, NC) was labeled with the fluorescent dye Cy3. Labeled complementary
RNA was then processed and hybridized to Agilent Mouse Arrays (catalog#
G4122F; ~44,000 features) according to the manufacturer’s protocol. Raw data
from scanned arrays were processed using Agilent’s Feature Extraction software
(v 7.5) according to the manufacturer’s instructions. Quality control reports
provided by the software were used to judge the quality of each array. No arrays
failed in this experiment. The output data were uploaded into the UNC
microarray database for storage and processing. Cy5:Cy3 ratios were generated
for each spot, and these values were normalized for intensity and spatially
dependent systematic variation by regional lowess smoothing (Cui et al., 2003).
Using the normalized data, the log2 of the Cy5:Cy3 ratios were obtained for
a given gene and used in subsequent analyses. The data are available from Gene
Expression Omnibus (GSE24278).
Data processing and analysis. Transcripts with over 30% missing values
across all samples were excluded from further analysis, reducing the data to
25,315 transcripts. Remaining missing values were imputed by a K-nearest
neighbor algorithm with K ¼ 2 neighbors. Samples were randomly assigned
into six separate batches for microarray experiments; no mice within the same
strain and treatment group were analyzed in the same batch. ANOVA revealed
a significant batch effect in 7299 transcripts (a ¼ 0.01; Benjamini-Hochberg
step-up false discovery rate [FDR] correction; Benjamini and Hochberg, 1995).
Batch effects were adjusted using the ComBat method (Johnson et al., 2007).
Principal components analysis (PCA) was used for exploratory analysis of
the transcript data (Joliffe, 2002). Distance weighted discrimination (DWD)
was used to examine global differences between TCE-treated and vehicle
samples (Marron et al., 2007). DWD finds a single direction providing good
separation between two sets of samples. DiProPerm, a randomization test based
on the DWD direction, was used to identify a significant overall difference
between the treated and the control groups. Randomization testing was used to
identify transcripts that contributed significantly to the discriminating direction.
PCA and DWD analyses were performed in MATLAB (Mathworks, Natick,
MA) using code available at www.unc.edu/~marron/marron_software.html.
ANOVA models were used to assess the significance of individual
transcripts. An ANOVA model with main effects for strain and treatment
and an interaction between strain and treatment were applied for each transcript.
Pearson correlation (transcript level and serum TCA at 24 h after treatment)
coefficients were calculated. ANOVA effects and correlations were concluded
to be significant if the p value (for the F statistic or t statistic, respectively) was
below a threshold determined by the step-up FDR procedure (Benjamini and
Hochberg, 1995) for multiple comparisons (a ¼ 0.01). The R programming
environment for statistical computing and graphics (2.10.0, R Development
Core Team, Vienna, Austria) was used for the ANOVA, correlation analysis,
and FDR adjustments. Heatmaps were generated using the Cluster (v 2.11) and
TreeView (v 1.60) applications (Eisen et al., 1998).
Ingenuity Pathway Analysis (Ingenuity Systems, Redwood City, CA)
software was used for functional analysis of the significant genes. Significance
of the enriched canonical pathways was determined by a right-tailed Fisher’s
exact test, with the step-up FDR correction for multiple comparisons. Gene
networks were constructed based on predefined molecular interactions in the
Ingenuity database.
Gene expression analysis by real-time PCR. Total RNA (2 lg) was
reverse transcribed using random primers and the high capacity complementary
DNA archive kit (Applied Biosystems, Foster City, CA) according to the
manufacturer’s protocol. The following gene expression assays (Applied
Biosystems) were used for quantitative real-time PCR: cytochrome P450,
family 4, subfamily a, polypeptide 10 (Cyp4a10, Mm01188913_g1);
peroxisome proliferator–activated receptor alpha (Ppara, Mm00440939_m1);
acyl-CoA thioesterase I, (Acot1, polypeptide A1, Mm01622471_s1); and beta
glucuronidase (Gusb, Mm00446953_m1). Reactions were performed in a 96-
well assay format. Each plate contained one experimental gene and
a housekeeping gene, and all samples were plated in duplicate. Reactions
were processed using Roche 480 instrument (Roche Applied Science,
Indianapolis, IN). The cycle threshold (Ct) for each sample was determined
from the linear region of the amplification plot. The DCt values for all genes
relative to the control gene Gusb were determined. The DDCt were calculated
using treated group means relative to strain-matched control group means. Fold
change data were calculated from the DDCt values.
Protein level and activity measurements. Liver tissue lysates were
prepared by homogenization of 30–40 mg of tissue in 500 ll of lysis buffer
(50mM Tris-HCl, pH 7.4; 1% nonyl phenosylpolyethoxylethanol 40; 1% SDS;
0.25% sodium deoxycholate; 150mM NaCl; 1mM EDTA; 1mM PMSF; 1 lg/
ml each aprotinin, leupeptin, and pepstatin; 1mM Na3VO4; and 1mM NaF),
sonication, and incubation at 4C for 30 min followed by centrifugation at
10,000 3 g at 4C for 20 min. Extracts containing equal quantities of proteins
were separated by SDS-PAGE on 10% polyacrylamide gels and transferred to
polyvinylidene fluoride membranes. Membranes were blocked in 5% nonfat
dry milk in PBS-T (0.1% Tween 20 in PBS), probed with 1:1000 anti-Cyp2E1
(Biomol, Plymouth Meeting, PA) and 1:2000 c-myc (Bethyl Laboratories Inc.,
Montgomery, TX), and incubated overnight at 4C. Blots were then washed in
tris buffered saline with tween incubated with the appropriate secondary
antibody, and detected using chemiluminescence Western blotting analysis kit
(Amersham, Pittsburgh, PA). Equal protein loading was confirmed by
immunostaining against b-actin (1:4000; Sigma-Aldrich Corporation, St Louis,
MO). The signal intensity was analyzed by ImageQuant software (Molecular
Dynamics, Sunnyvale, CA) and normalized to b-actin. Cyp2e1 activity was
measured by the rate of hydroxylation of p-nitrophenol to p-nitrocatechol by
isolated hepatic microsomes prepared as detailed in Koop (1986).
RESULTS
TCE (2100 mg/kg) or corn oil vehicle was administered by
gavage to 6- to 8-week-old male mice of 15 inbred strains.
A single dose of TCE (2100 mg/kg, i.g. in corn oil vehicle) did
not lead to adverse effects in liver or kidney as assessed by
histopathology (data not shown). As expected (Yuan et al.,
2009), the activity of serum AST and ALT, as well as levels of
BUN, varied between strains (Supplementary table 1). TCE
had no effect at either of the time points examined (2, 8, and
24 h) with regard to AST or BUN. A marginal, yet significant,
increase in serum ALT (at 24 h) was observed only in 129S1/
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SvlmJ and CAST/EiJ strains. Body weight, liver weight, and
liver:body weight ratios were also recorded (Supplementary
table 1), and no significant (p < 0.05) effect of TCE treatment
was observed at all time points.
Serum concentration-time profiles of four oxidative and glu-
tathione conjugation metabolites of TCE were examined (Fig. 1,
Supplementary table 2). A more than fourfold difference in peak
serum concentrations of TCA (at 8 h), the main product of TCE
metabolism in mice (Lash et al., 2000a), was found across the
individual strains. An ANOVA was used to evaluate the
metabolite differences as a function of strain at each time point.
For TCA, a significant (p < 0.01) strain effect was observed at 8
and 24 h (R2 of 0.73 and 0.87 for the fraction of variation due to
strain at each time point, respectively). The amount of TCA
formed over a 24-h period after single dosing (estimated by
using the area under the curve from the concentration-time
profiles) across strains was significantly correlated (r2 ¼ 0.499,
p < 0.05) with the basal liver levels of Cyp2e1 protein (data not
shown).
Although the levels of DCA in serum were approximately
1000-fold lower than those of TCA, similar to observations
reported earlier (Kim et al., 2009a; Sano et al., 2009),
considerable differences in concentration-time profiles and
peak levels of DCA also exist between strains. Serum levels of
DCVG and DCVC were the lowest of the four TCE
metabolites assessed in this study and were below the limit
of quantification in some strains, especially at 8- and 24-h time
points. A significant strain effect from an ANOVA model was
observed for DCA at 8 and 24 h (R2 of 0.69, p < 0.01, and
0.86, p < 0.05, respectively) and DCVG at 2 h (R2 ¼ 0.67, p <
0.05). Serum levels of DCA, DCVG, or DCVC did not
correlate with Cyp2e1, as expected (Kim et al., 2009a).
The regulatory pathways that control gene expression levels
in liver and other tissues are known to be influenced by genetic
factors, which results in considerable differences in messenger
RNA (mRNA) levels between individuals even in the absence
of any exogenous stimuli (Chesler et al., 2003; Gatti et al.,
2007). In order to evaluate liver effects of TCE in the
individual strains, microarray-based analysis was performed on
tissues collected at 24 h after dosing. The PCA of the liver
transcriptome data collected in this study revealed a strong
strain effect, which concealed the TCE treatment effect
(Figs. 2A–C). The wild-derived strains CAST/EiJ, MOLF/
EiJ, and PWD/PhJ were most divergent with regards to liver
transcriptome (principal component 1, Fig. 2A), an observation
reported previously (Gatti et al., 2009), as they are most
genetically distinct from other strains.
Despite these major differences, a highly significant (p <
0.001) effect of TCE could be observed across the entire
population using DWD analysis, which considers a global dis-
tinction between TCE- and vehicle-treated animals (Figs. 2D
and 2E). A DWD direction-derived signature consisting of 29
transcripts that were significantly discriminating between TCE
and vehicle groups (a ¼ 0.01; step-up FDR correction) was
established (Fig. 2F, Supplementary table 3). The signature
was enriched in genes that were strongly associated with lipid
metabolism, small molecule biochemistry, and nucleic acid
metabolism pathway (Ingenuity score 9) centered on PPARa
and PPARc (Fig. 3A). Interestingly, two well-known PPARa-
regulated genes, Cyp4a10 (Barclay et al., 1999) and Acot1
(Dongol et al., 2007), were among the most discriminating
FIG. 3. (A) Network representation of the genes identified as significantly
discriminating among vehicle- and TCE-treated groups (see Fig. 2E). Ingenuity
analysis software was used to visualize the molecular interactions between the
genes in lipid metabolism, small molecule biochemistry, and nucleic acid
metabolism pathways. Expression differences for Cyp4a10 (B) and Acot1 (C)
genes were confirmed using PCR.
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FIG. 4. Strain-independent effects of TCE on mouse liver transcriptome. (A) Venn diagram showing genes that were significant in the ANOVA comparing the
effects of strain, treatment, and strain 3 treatment interaction. (B) A heatmap of the 72 genes identified as significant for the effect of TCE treatment, but not significant
for strain or interaction effects. These genes can be regarded as TCE-responsive independent of the individual’s genetic background. See Supplementary table 4 for
a complete list of genes, gene expression values, and significance values. (C) A network representation of the 72 genes identified as significantly associated with TCE
treatment. Molecular interactions between the genes in cell death, liver necrosis, and inflammatory-mediated response are visualized. Upregulated genes are identified
in red and downregulated in green. (D) Protein levels of c-Myc were determined using Western immunoblotting in representative strains.
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genes with regards to TCE effect in the population of strains.
Whereas expression of Ppara, a transcription factor, did not
change in response to this short-term treatment (data not
shown), mRNA induction of Ppara-target genes Cyp4a10 and
Acot1 were confirmed using real time-PCR and shown to be
elevated in most but not all strains (Figs. 3B–C).
To further evaluate the changes in gene expression, an
ANOVA model was fit for each transcript with main effects for
strain (i.e., genotype), treatment (vehicle or TCE), or an
interaction effect between the two because of the observed
genotype-specific effects on TCE metabolism (Fig. 1). The
number of transcripts significantly altered by each of these
experimental factors is depicted in a Venn diagram (Fig. 4A).
Of the 25,315 transcripts used for the analysis (see ‘‘Materials
and Methods’’ section), 20,303 had a significant strain effect,
1199 a significant treatment effect, and 37 were significant for
treatment 3 strain interaction. There were 72 transcripts with
a significant treatment effect, yet without a significant strain or
interaction effect (Fig. 4B, Supplementary table 4). The
expression of these transcripts was significantly affected by
TCE treatment, but not the subject’s genotype, and we posit
that these transcripts could serve as population-based bio-
markers of response to TCE. The cell death, necrosis, and
inflammatory-mediated response molecular network (Ingenuity
score 20) centered on tumor necrosis factor a and myelocy-
tomatosis oncogene Myc was enriched among these popula-
tion-based transcripts (Fig. 4C). Transcription factor analysis of
these genes was performed using the Pscan (Zambelli et al.,
2009) tool and Transfac database (Biobase GmbH, Wolf-
enbuettel, Germany) to determine common regulators. In-
terestingly, inflammation-related regulatory proteins, Myc-
associated zinc finger protein-related factor (MAZR), activat-
ing enhancer-binding protein 2 alpha (AP2a), and specificity
protein 1 (SP1), may be common regulators of the strain-
independent TCE-induced inflammatory response in mouse
liver (Table 1). Indeed, changes in c-Myc protein levels
between strains were in accord with mRNA levels (Fig. 4D).
We also examined whether some transcripts were signifi-
cantly associated with TCE metabolism. Correlation coeffi-
cients were calculated for each transcript with serum
concentrations of TCA and DCA, two main oxidative
metabolites of TCE. Glutathione conjugates were not used in
this analysis because they were not detectable at 24 h after
treatment. The correlation analysis with serum levels of DCA
did not yield any significant transcripts; however, there were
126 transcripts found to have a significant correlation with
TCA levels in serum at 24 h (Fig. 5A). Most of these
transcripts (124 of 126) also had a significant strain effect,
consistent with the observed strain-dependent differences in
TCE metabolism (Fig. 1). Of these, 60 transcripts exhibited
a significant treatment effect (Fig. 5B, Supplementary table 5).
These can be regarded as genetic background–dependent
markers of TCE metabolism. The fatty acid metabolism
canonical pathway (Ingenuity score 19), which includes
PPARa, c, and other transcripts involved in lipid metabolism,
small molecule biochemistry, and molecular transport, was the
top network enriched in these 60 genes (Fig. 5C). Similarly, the
gene ontology biological process GO:0006631 (fatty acid
metabolic process) was the only significant (FDR < 0.05)
pathway enriched in this gene list.
DISCUSSION
Studies of species differences in liver effects of TCE are
important for assessing the risk of human exposure (Lash et al.,
2002; Lumpkin et al., 2003; Sano et al., 2009). It is widely
accepted that oxidative metabolism of TCE is a key event for
liver toxicity, and there are important quantitative differences
among species with regard to formation of two major
metabolites, TCA and DCA (NRC, 2006). These molecules
are hepatocarcinogenic themselves in the mouse, yet are
thought to operate through different molecular pathways
(Corton, 2008). TCA-induced mouse liver tumors have
molecular features similar to those induced by typical
peroxisome proliferators (Bull et al., 2002; Latendresse and
Pereira, 1997). Even though TCE induces peroxisome pro-
liferation, TCE-induced tumors exhibit a number of important
dissimilarities as compared with TCA-induced tumors, which
led to a suggestion that the mode of action for TCE
hepatocarcinogenesis is different from that of TCA (Corton,
2008). Thus, the issue of quantitative assessment of TCE
metabolism is an important challenge in relating adverse health
effects in rodents to humans (NRC, 2006). Importantly, we
show that in addition to differences in TCE metabolism
between species, there are important differences between
individuals within the same species.
The relative amounts of TCA and DCA being formed as
a result of TCE administration has been determined in several
studies. Although some still debate whether DCA is formed
in vivo in quantifiable levels (Merdink et al., 2008), several recent
studies showed that DCA can be detected; however, serum
concentrations are more than 1000-fold lower than those for TCA
(Delinsky et al., 2005; Kim et al., 2009a,b; Sano et al., 2009).
Our study confirms this and shows that DCA and TCA serum
concentrations do not correlate with each other, supporting the
pharmacokinetic model suggesting that the metabolism of TCA
to DCA is not a major pathway for the formation of DCA in the
mouse (Kim et al., 2009b). At the same time, we show that the
interstrain differences in serum TCA correlate well with liver
Cyp2e1, an enzyme which is known to be a major oxidase for
metabolizing TCE to TCA (Lash et al., 2000a).
Furthermore, this study provides additional evidence that, in
the mouse, the glutathione pathway of TCE metabolism plays
a minor role. We show that very low levels (~10,000-fold less
than TCA) of DCVG and DCVC are formed, that this
phenomenon is reproducible across multiple inbred mouse
strains, and that these metabolites are rapidly eliminated after
a single large dose of TCE when administered in corn oil
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FIG. 5. Strain-dependent gene expression signature, which correlates with TCA levels in serum. (A) Venn diagram showing genes that were significant in the
ANOVA with effects for strain and treatment and correlate with serum TCA (24 h after TCE treatment) levels. (B) A heatmap of the 60 genes identified as
significant for both TCE treatment and levels of TCA in serum following exposure. These genes are also significant for the strain effect, which suggests that TCE
metabolism is dependent on the individual’s genetic background. See Supplementary table 5 for a complete list of genes, gene expression values, and significance
values. (C) A network representation of the 60 genes identified as significantly associated with TCE treatment and serum TCA level.
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vehicle. It has been suggested that the extent of formation of
glutathione conjugates from TCE in humans is much higher than
in rodents based on high blood concentrations of DCVG
reported in humans after inhalation of TCE (Lash et al., 1999).
The same group studied formation of glutathione conjugates in
rats after single large oral dose of TCE and reported that DCVG
concentrations in blood and urine were high, yet not dose or time
dependent (Lash et al., 2006). Other groups have reported a very
low rate of glutathione conjugates’ formation in vivo in rats
(Dekant et al., 1990) and mice (Kim et al., 2009a,b). Thus, the
findings reported herein provide additional important informa-
tion for rodent-to-human extrapolations with regard to TCE
metabolism, which is critical for dose-response analysis and
derivation of the reference values in risk assessment.
To better understand the differences in the molecular events
elicited by TCE in the mouse liver, we evaluated both strain-
dependent and independent gene expression changes. Genetic
polymorphisms play a major role in influencing gene
expression in liver (Gatti et al., 2007) and other tissues
(Bystrykh et al., 2005; Chesler et al., 2005), an effect that is
often stronger than that of a toxicant (Harrill et al., 2009).
When genetic background–dependent gene expression differ-
ences between strains are not taken into the account, the
population-wide TCE-induced gene expression changes were
found to be related to the peroxisomal proliferation mode of
action. Indeed, TCE is well known to cause many liver effects
in mice in a PPARa-dependent manner (Laughter et al., 2004;
Nakajima et al., 2000). Even though we did not find PPAR
genes themselves to be induced 24 h after treatment with TCE,
similar to the observation of Sano et al. (2009), the targets of
these transcription factors were strongly upregulated in the
overwhelming majority of the strains. This is indicative of the
fact that the peroxisomal proliferation effect of TCE is
occurring consistently in all strains.
Interestingly, when correlations between TCE metabolism to
TCA or to gene expression changes were considered in the
context of strain, we found that almost all the genes were also
significantly impacted by the genetic background effect. This
observation is in agreement with the fact that major strain-
dependent differences in TCE metabolism exist. Induction of
a lipid and drug metabolism network of genes centered on
PPARs was the major molecular signature of this correlation
analysis, consistent with the fact that TCA was the major
metabolite of TCE in all strains and that it is a ligand for
PPARs (Maloney and Waxman, 1999).
The interstrain variability in TCE metabolism observed in
this study resulted in little observable liver toxicity (marginal
increases in ALT observed in 2 out of 15 strains) when liver
histopathology was considered. Acute single-dose exposures
have not been associated with liver injury. The studies of
Ramdhan et al. are the shortest that showed liver toxicity in
mice following 7 days of inhalation exposure to TCE, an effect
that was dependent on Cyp2e1 (Ramdhan et al., 2008), but not
PPARa (Ramdhan et al., 2010).
The mechanism for TCE-induced liver damage has not been
well studied, but it has been suggested that induction of nuclear
factor-kappa-light-chain enhancer of activated B cells-activated
cytokine pathways may be responsible for hepatotoxicity
(Ramdhan et al., 2008, 2010). Thus, it is interesting that we
find that cell death, liver necrosis, and inflammatory-mediated
response networks are altered by TCE treatment, and it is
genetic background independent. This further suggests that
liver damage may not depend solely on TCE metabolism to
potentially hepatotoxic intermediates, such as chloral hydrate
or DCA, and that sufficient amounts of hepatotoxic inter-
mediates are formed in all strains in spite of a four- to sixfold
difference in TCE metabolites.
The transcription factor analysis of the genes that were altered
by TCE independent of genetic background revealed several
inflammation-related regulatory proteins, MAZR, AP2a, and
SP1, which may be common regulators involved in TCE-induced
inflammatory response in mouse liver. MAZR transactivates the
Myc gene in B cells and is important for the development of B
cells in association with Bach2 (Kobayashi et al., 2000). AP2 is
involved in a number of inflammatory pathways including
NFjB, cyclooxygenase-2, and inducible nitric oxide synthase, as
well as PPARc (Makowski et al., 2005). SP1 is one of key
regulators of acute-phase response inflammatory genes in
hepatocytes (Cantwell et al., 1998). Because these transcription
factors have been shown to be associated with activation of
macrophages and lymphocytes, the gene expression signature
reported in this study suggests that TCE may have an effect on
Kupffer cells, a hypothesis which needs to be tested.
It has been suggested that PPARa may be protective against
liver injury, at least in the short-term exposure scenarios
(Ramdhan et al., 2008). Interestingly, a recent study in-
vestigating the effects of TCE in Ppara-null and humanized
mice showed that PPARa and PPARc may be important
factors in TCE-induced lipid accumulation in the liver but that
TCE-induced liver toxicity was largely independent of PPARa
status and also occurred in humanized mice (Ramdhan et al.,
2010). The authors also reported that human PPARa may
afford only weak protection against TCE-mediated effects as
compared with mouse PPARa (Ramdhan et al., 2010). This
observation is of importance for consideration of species-
specific differences in TCE toxicity as data exist from human
occupational exposure studies suggesting that exposures to TCE
may lead to acute and chronic liver injury (Pantucharoensri
et al., 2004; Thiele et al., 1982). Our observation that induction
of PPARa-mediated pathways by TCE is dependent on strain
and thus an individual’s genetic background and further sup-
ports a need for additional studies elucidating the role of
PPARa beyond peroxisome proliferation effects.
We also observed that Myc was induced by TCE. This
observation is in agreement with the studies of Tao et al.
(2000) who found decreased methylation in the promoter
regions of the Jun and Myc genes and increased levels of their
mRNA and proteins in mice exposed to TCE, DCA, and TCA.
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It has been suggested that a rapid increase in proliferation
caused by most peroxisome proliferators would prevent the
methylation of the newly synthesized strands of DNA (Ge
et al., 2001). Indeed, the temporal relationship between
increased cell proliferation and DNA hypomethylation of the
Myc gene was observed in a study after single administration of
another peroxisome proliferative agent WY-14643 to mice (Ge
et al., 2001). Importantly, this short-term effect is not sustained
because subchronic and chronic administration of WY-14643
has no effect on Myc methylation; however, major changes in
DNA methylation occurred (Pogribny et al., 2007, 2008).
Thus, it must be established whether upregulation of Myc by
TCE is playing a role in long-term effects and what is
a temporal relationship between cell proliferation and its
promoter methylation and expression levels.
In conclusion, this study shows that important interindividual
differences exist in TCE metabolism and molecular signaling
in the liver. The biologically relevant exposure metrics collected
in this study, both assessment of TCE metabolites and
toxicogenomic-based evaluation, allow for better understanding
of the association between key events and an individual’s
genotype. Although it is widely accepted that toxicogenomics
has great potential to yield a new generation of exposure metrics
and mode of action information (Cui and Paules, 2010), it is also
important to understand which of the gene expression changes
may be indicative of the population-wide versus an individual’s
response. Although further research is needed to find genetic and
genomic markers that could identify individuals susceptible to
TCE toxicity, this study provides important clues which point to
liver inflammatory responses as being a population-wide
response, although the extent of TCE metabolism and peroxi-
somal proliferation, at least in the mouse, may be dependent
on an individual’s genotype. A careful evaluation of gene
expression–based biomarkers of response through multistrain
experiments can assist in understanding the molecular basis of
interindividual differences in metabolism and toxicity.
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